Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT01512550
Eligibility Criteria:
Inclusion Criteria:
* Osteoarthritis (OA) of the hip necessitating primary total hip arthroplasty (THA)
* Male and non-pregnant female patients
* Hip bone quality and morphology suitable for uncemented THA
* Age up to 75 years old at the inclusion time of the study
* Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up.
* Patients who are capable of, and have given informed consent for participation in the study.
Exclusion Criteria:
* Rheumatoid arthritis
* Malignant disease
* Severe osteoporosis
* Patients with active infection
* Patients with malignancy
* Prior major surgery in the hip to be operated on
* Peroperative fracture
* Hip prosthesis or grossly distorted hip anatomy in the contralateral hip.
* Ongoing corticosteroid (oral) or immunosuppressive medication
* Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.
* Patients with concurrent illnesses which are likely to affect their outcome.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT01512550
Study Brief:
Protocol Section:
NCT01512550